pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
Psychiatry & CNS · news · pharmadog
← back to Psychiatry & CNS
News · Psychiatry & CNS
14
stories
Apr 25, 26
Nancy Cox, a CDC veteran and a stalwart in global flu research, dies at 77
stat
Apr 24, 26
STAT+: FDA to speed up review of three psychedelics as mental health treatments
stat
Apr 24, 26
STAT+: Utah medical board calls for immediate suspension of state’s AI doctor experiment
stat
Apr 24, 26
Lilly tumbles on Foundayo’s shaky week; FDA to issue vouchers for psychedelics
biopharma dive
Apr 24, 26
International childhood vaccine campaign grows
stat
Apr 24, 26
STAT+: Sanofi MS drug gets positive review in Europe following FDA
stat
Apr 24, 26
Opinion: I started medical school at 69 and will begin residency at 72. Here’s what I learned
stat
Apr 24, 26
Psychedelics get a boost from the White House
stat
Apr 24, 26
Opinion: The local news crisis is also a public health crisis
stat
Apr 24, 26
Growing use of guest editors has turned some journals into a ‘playground of bad science’
stat
Apr 23, 26
STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead
stat
Apr 23, 26
Heart’s beat may help it beat cancer, mouse research suggests
stat
Apr 23, 26
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy
stat
Apr 23, 26
STAT+: Sanofi research priorities in flux as new CEO logs in
stat
